Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had revenue of $44.04M in the quarter ending September 30, 2025, with 13.57% growth. This brings the company's revenue in the last twelve months to $142.53M, down -3.98% year-over-year. In the year 2024, Karyopharm Therapeutics had annual revenue of $145.24M, down -0.55%.

• Revenue (ttm): $142.53M
• Revenue Growth: -3.98%
• P/S Ratio: 0.42
• Revenue / Employee: $510,860
• Employees: 279
• Market Cap: 118.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	145.24M	-796.00K	-0.55%
Dec 31, 2023	146.03M	-11.04M	-7.03%
Dec 31, 2022	157.07M	-52.75M	-25.14%
Dec 31, 2021	209.82M	101.73M	94.12%
Dec 31, 2020	108.09M	67.19M	164.31%
Dec 31, 2019	40.89M	10.56M	34.80%
Dec 31, 2018	30.34M	28.73M	1,790.09%
Dec 31, 2017	1.61M	1.45M	942.21%
Dec 31, 2016	154.00K	-96.00K	-38.40%
Dec 31, 2015	250.00K	21.00K	9.17%
Dec 31, 2014	229.00K	-158.00K	-40.83%
Dec 31, 2013	387.00K	-247.00K	-38.96%
Dec 31, 2012	634.00K	482.00K	317.11%
Dec 31, 2011	152.00K	-	-